OPC-21268 [Ligand Id: 2196] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL296908 (OPC-1268, OPC-21268)
There should be some charts here, you may need to enable JavaScript!
  • V1A receptor/Vasopressin V1a receptor in Human [ChEMBL: CHEMBL1889] [GtoPdb: 366] [UniProtKB: P37288]
  • V1A receptor/Vasopressin V1a receptor in Rat [ChEMBL: CHEMBL2868] [GtoPdb: 366] [UniProtKB: P30560]
There should be some charts here, you may need to enable JavaScript!
  • V2 receptor/Vasopressin V2 receptor in Human [ChEMBL: CHEMBL1790] [GtoPdb: 368] [UniProtKB: P30518]
  • V2 receptor/Vasopressin V2 receptor in Rat [ChEMBL: CHEMBL3766] [GtoPdb: 368] [UniProtKB: Q00788]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
OT receptor/Oxytocin receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2049] [GtoPdb: 369] [UniProtKB: P30559]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from human. B 6.77 pKi 170 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]-oxytocin from oxytocin receptor in human uterus tissue B 6.77 pKi 170 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
GtoPdb - - 6.8 pKi - - - Life Sci (1995) 57: 2253-61 [PMID:7475979]
OT receptor/Oxytocin receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3996] [GtoPdb: 369] [UniProtKB: P70536]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]-OT (oxytocin) from specific binding sites in uterine tissue obtained from rats B 6.64 pKi 230 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]-oxytocin from oxytocin receptor in rat uterus tissue B 6.64 pKi 230 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
V1A receptor/Vasopressin V1a receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1889] [GtoPdb: 366] [UniProtKB: P37288]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in human platelets. B 4.28 pKi 52000 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]vasopressin from vasopressin V1a receptor in human liver tissue B 4.28 pKi 52000 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
ChEMBL Binding affinity towards Vasopressin V1a receptor in human liver B 4.85 pKi 14000 nM Ki J Med Chem (2000) 43: 4388-4397 [PMID:11087564]
ChEMBL Binding affinity at cloned human Vasopressin V1a receptor stably expressed in CHO cells, using [3H]AVP as radioligand B 5 pKi >10000 nM Ki J Med Chem (2002) 45: 2589-2598 [PMID:12036368]
GtoPdb - - 5.1 pKi - - - Endocrinology (1997) 138: 4109-22 [PMID:9322919]
ChEMBL Binding affinity to vasopressin V1a receptor B 6.46 pKi 350 nM Ki J Nat Prod (1994) 57: 1329-1335 [PMID:7807119]
V1A receptor/Vasopressin V1a receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2868] [GtoPdb: 366] [UniProtKB: P30560]
ChEMBL Binding affinity towards Vasopressin V1a receptor in rat liver B 7.49 pKi 32 nM Ki J Med Chem (2000) 43: 4388-4397 [PMID:11087564]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in rat liver. B 7.49 pKi 32 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]vasopressin from vasopressin V1a receptor in rat liver tissue B 7.49 pKi 32 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
ChEMBL Evaluated for the binding affinity towards Vasopressin V1a receptor in rat liver membrane using [3H]AVP as radioligand B 7.63 pKi 23.5 nM Ki Bioorg Med Chem Lett (2002) 12: 229-232 [PMID:11755361]
ChEMBL Binding affinity at Vasopressin V1a receptor, performed using [3H]AVP on rat liver B 7.63 pKi 23.5 nM Ki J Med Chem (2002) 45: 2589-2598 [PMID:12036368]
ChEMBL Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V1 receptor) B 6.36 pIC50 440 nM IC50 J Med Chem (1993) 36: 2011-2017 [PMID:8393113]
V2 receptor/Vasopressin V2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1790] [GtoPdb: 368] [UniProtKB: P30518]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in kidney medulla obtained from early postmortem human donors. B 4.09 pKi >81000 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]vasopressin from vasopressin V2 receptor in human kidney tissue B 4.09 pKi >81000 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
GtoPdb - - 4.5 pKi - - - Endocrinology (1997) 138: 4109-22 [PMID:9322919]
ChEMBL Binding affinity at cloned human Vasopressin V2 receptor stably expressed in CHO cells, using [3H]AVP as radioligand B 5 pKi >10000 nM Ki J Med Chem (2002) 45: 2589-2598 [PMID:12036368]
V2 receptor/Vasopressin V2 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3766] [GtoPdb: 368] [UniProtKB: Q00788]
ChEMBL Binding affinity was evaluated by measuring the displacement of [3H]AVP (arginine vasopressin) from specific binding sites in kidney medulla obtained from rats. B 4.52 pKi >30000 nM Ki J Med Chem (1995) 38: 4634-4636 [PMID:7473590]
ChEMBL Displacement of [3H]vasopressin from vasopressin V2 receptor in rat kidney tissue B 4.52 pKi >30000 nM Ki J Med Chem (2010) 53: 6525-6538 [PMID:20550119]
ChEMBL Evaluated for the binding affinity towards Vasopressin V2 receptor in rat kidney membrane using [3H]-AVP as radioligand B 5 pKi >10000 nM Ki Bioorg Med Chem Lett (2002) 12: 229-232 [PMID:11755361]
ChEMBL Binding affinity at Vasopressin V2 receptor, performed using [3H]AVP on rat kidney B 5 pKi >10000 nM Ki J Med Chem (2002) 45: 2589-2598 [PMID:12036368]
ChEMBL Ability to displace [3H]- Arginine Vasopressin (AVP) from its specific binding sites in rat liver (V2 receptor) B 4 pIC50 >100000 nM IC50 J Med Chem (1993) 36: 2011-2017 [PMID:8393113]

ChEMBL data shown on this page come from version 34:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]